Defective Remodeling of Cardiolipin and Phosphatidylglycerol in Barth Syndrome
Top Cited Papers
- 1 December 2000
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 279 (2) , 378-382
- https://doi.org/10.1006/bbrc.2000.3952
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Absence of Cardiolipin in the crd1 Null Mutant Results in Decreased Mitochondrial Membrane Potential and Reduced Mitochondrial FunctionJournal of Biological Chemistry, 2000
- X-linked cardioskeletal myopathy and neutropenia (Barth syndrome)—MIM 302060The Journal of Pediatrics, 1999
- The PEL1 Gene (Renamed PGS1) Encodes the Phosphatidylglycero-phosphate Synthase ofSaccharomyces cerevisiaeJournal of Biological Chemistry, 1998
- Purification and Characterization of Phosphatidylglycerolphosphate Synthase from Schizosaccharomyces pombePublished by Elsevier ,1998
- The acylation of lysophosphatidylglycerol in rat heart: evidence for both in vitro and in vivo activitiesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- A novel X-linked gene, G4.5. is responsible for Barth syndromeNature Genetics, 1996
- X‐linked cardioskeletal myopathy and neutropenia (Barth syndrome): Respiratory‐chain abnormalities in cultured fibroblastsJournal of Inherited Metabolic Disease, 1996
- Mitochondrial cardiolipin in diverse eukaryotesEuropean Journal of Biochemistry, 1993
- X-linked dilated cardiomyopathy with neutropenia, growth retardation, and 3-methylglutaconic aciduriaThe Journal of Pediatrics, 1991
- Phenotypic heterogeneity in the syndromes of 3-methylglutaconic aciduriaThe Journal of Pediatrics, 1991